MedTrace Logo

Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation

NCT02860585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 235

Last updated 2017-09-26

No results posted yet for this study

Summary

The objective of this study was to evaluate the outcome of patients affected with different subtypes of metastatic breast cancer following treatment with high-dose chemotherapy and autologous haematopoietic progenitor cell transplantation.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

  • Institut Paoli-Calmettes

    lead OTHER

Principal Investigators

  • Christian Chabannon, MD,PhD · Institut Paoli-Calmettes

  • Anthony Gonçalves, MD,PhD · Institut Paoli-Calmettes

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-27
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02860585 on ClinicalTrials.gov